Indium-111 activity concentration in tissue samples after intravenous injection of indium-111-DTPA-D-Phe-1-octreotide.

• Indium-111 activity concentrations in human tumor and normal tissue samples were determined at 24, 48 and 120 hr after i.v. injection of 111In-DTPA-D-Phe-1-octreotide. Fourteen patients were included in the study. Seven patients had medullary thyroid carcinoma, four had midgut carcinoid tumors, two had endocrine pancreatic tumors and one had chronic pancreatitis.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Gastroenterologi (hsv//swe)

MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Gastroenterology and Hepatology (hsv//eng)

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Kirurgi (hsv//swe)

MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Surgery (hsv//eng)

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Radiologi och bildbehandling (hsv//swe)

MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Radiology, Nuclear Medicine and Medical Imaging (hsv//eng)

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Cancer och onkologi (hsv//swe)

MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cancer and Oncology (hsv//eng)

Keyword

Abdominal Neoplasms

radionuclide imaging

Adult

Aged

Carcinoid Tumor

radionuclide imaging

Chronic Disease

Female

Humans

Indium Radioisotopes

administration & dosage

pharmacokinetics

Injections

Intravenous

Male

Middle Aged

Neuroendocrine Tumors

metabolism

radionuclide imaging

Octreotide

administration & dosage

analogs & derivatives

pharmacokinetics

Pancreatic Neoplasms

radionuclide imaging

Pancreatitis

radionuclide imaging

Pentetic Acid

administration & dosage

analogs & derivatives

pharmacokinetics

Receptors

Somatostatin

metabolism

Reference Values

Thyroid Neoplasms

radionuclide imaging

Publication and Content Type

ref (subject category)

art (subject category)